Advertisement
-
-
Metabolic diseases in the East Asian populations
The East Asian population is experiencing a continuous rise in metabolic disease burden. This Review provides a detailed account of epidemiological data and discusses risk factors and therapeutic approaches, offering valuable insights into region-specific drivers and therapeutic strategies.
-
-

MASLD/NAFLD
Fuelled by increasing obesity rates, metabolic dysfunction associated steatotic liver disease (MASLD, formerly known as NAFLD) has emerged as a leading global cause of chronic liver disease in the past few decades. Despite growing prevalence, the factors influencing MASLD development and subsequent progression to metabolic dysfunction associated steatohepatitis (MASH), liver fibrosis, cirrhosis and hepatocellular carcinoma are poorly understood. In this article series, Nature Reviews Gastroenterology & Hepatology explores the epidemiology of MASLD, disease mechanisms and therapeutics, and clinical approaches to diagnosis and management.